Genobio Successfully Registered CE-IVDR for Its Instruments
Tianjin, China – October 7, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and...
Invasive candidiasis is a frequent life-threatening complication in critically ill patients. Early diagnosis followed by prompt treatment aimed at improving outcome by minimizing unnecessary antifu...
Tianjin, China – August 9, 2022 – Tianjin Era Biology Technology Co., Ltd was award as National Professionalization, Refinement, Characteristic and Novelty “Little Giant” by National Ministry of In...
(1,3)-β-D-Glucan is a component of the cell walls of many fungal organisms. Scientists investigate the feasibility of the BG assay and its contribution to early diagnosis of different types of inva...
Era Biology at ECCMID 2023, Denmark
Era Biology, a leader and pioneer of invasive fungal disease (IFD) diagnostics field, has exhibited at the European Congress of Clinical Microbiology and Infecti...